Existing evidence for osteoprotegerin's important role in tumor progression and metastasis of colorectal carcinoma prompted us to examine its expression in colorectal liver metastasis tissue samples and to investigate its potential relationship with clinicopathological characteristics and clinical outcomes of patients with colorectal liver metastasis. This evidence concerns the gene TNFRSF11B and neoplasm.